 |
|
Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
Michael Dreher, Tobias Müller
Tuberc Respir Dis. 2018;81(1):1-5. Published online 2017 Dec 13 DOI: https://doi.org/10.4046/trd.2017.0102
|
|
Citations to this article as recorded by
 PEGylation improves the therapeutic potential of dimerized translationally controlled tumor protein blocking peptide in ovalbumin-induced mouse model of airway inflammation
Hyeran Seo, Hae-Duck Bae, Haejun Pyun, Bo-Gyu Kim, Sang-Il Lee, Jin-Sook Song, Kyunglim Lee
Drug Delivery.2022; 29(1): 2320. CrossRef Comparing Inhaler Use Technique Based on Inhaler Type in Elderly Patients with Respiratory Disease
Ha Youn Lee, Jin Hwa Song, Ha-Kyeong Won, Yeonkyung Park, Keun Bum Chung, Hyo-Jeong Lim, Young Mee Ahn, Byoung Jun Lee
Tuberculosis and Respiratory Diseases.2021; 84(1): 46. CrossRef Effect of omalizumab as add-on therapy to Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) in Korean patients with severe persistent allergic asthma
Jae-Woo Jung, Hae-Sim Park, Choon-Sik Park, Sang-Heon Cho, Inseon S. Choi, Hee-Bom Moon, Soon Seog Kwon, Ho Joo Yoon, Jung Won Park, Jong-Myung Lee, Dong-Chull Choi, Byoung Whui Choi
The Korean Journal of Internal Medicine.2021; 36(4): 1001. CrossRef Exposure to Docetaxel in the Elderly Patient Population: a Population Pharmacokinetic Study
Marie-Rose B. S. Crombag, Thomas P. C. Dorlo, Ellen van der Pan, Anoek van Straten, Andries M. Bergman, Nielka P. van Erp, Jos H. Beijnen, Alwin D. R. Huitema
Pharmaceutical Research.2019;[Epub] CrossRef
|